Sunshine Guojian Pharmaceutical(Shanghai) Co.,Ltd. Posted 89.2 Million Yuan Net Profit in First Half of 2023

Sunshine Guojian Pharmaceutical(Shanghai) Co.,Ltd. (三生国健药业(上海)股份有限公司) (688336.SH) reported a net profit of 89.2 million yuan in the first half of 2023, reversing a net loss of 13.1 million yuan for the same period in the previous year.

Meanwhile, the company posted 477.8 million yuan in revenue, up 40.3% year-on-year.

At the end of the reporting period, it had 5 billion yuan in total assets and 343.8 million yuan in total liabilities, with a liability-to-asset ratio of 6.8%.